Ross\Johnson & Associates’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$966 Buy
+2
New +$531 0.02% 94
2026
Q1
Sell
-1
Closed -$166 349
2025
Q4
$166 Buy
+1
New +$167 ﹤0.01% 266

Other funds holding ALAB

Ross\Johnson & Associates's ALAB Position: Q2 2026 in Review

Ross\Johnson & Associates opened a new position in Astera Labs (ALAB) in Q2 2026: 2 shares worth $966. The stake represents 0.02% of the portfolio and ranks #94 among its holdings. This is a return to the name: Ross\Johnson & Associates previously reported a position in ALAB as recently as Q4 2025.

Ross\Johnson & Associates first reported a position in ALAB in Q4 2025 and has held it in 2 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Ross\Johnson & Associates held 2 shares of Astera Labs worth $966 as of Q2 2026.
  • Astera Labs was a new Ross\Johnson & Associates position in Q2 2026.
  • Astera Labs made up 0.02% of Ross\Johnson & Associates's portfolio in Q2 2026, its #94 holding.
  • Ross\Johnson & Associates first reported a position in Astera Labs in Q4 2025 and has held it in 2 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Ross\Johnson & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.